X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PFIZER UNICHEM LAB/
PFIZER
 
P/E (TTM) x 24.1 30.6 78.7% View Chart
P/BV x 2.3 5.2 43.8% View Chart
Dividend Yield % 1.1 0.6 180.5%  

Financials

 UNICHEM LAB   PFIZER
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
PFIZER
Mar-16
UNICHEM LAB/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3202,724 11.7%   
Low Rs2211,611 13.7%   
Sales per share (Unadj.) Rs167.2440.9 37.9%  
Earnings per share (Unadj.) Rs12.048.7 24.6%  
Cash flow per share (Unadj.) Rs16.975.8 22.3%  
Dividends per share (Unadj.) Rs3.0015.00 20.0%  
Dividend yield (eoy) %1.10.7 160.3%  
Book value per share (Unadj.) Rs117.0462.9 25.3%  
Shares outstanding (eoy) m90.8845.75 198.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.64.9 32.9%   
Avg P/E ratio x22.644.5 50.8%  
P/CF ratio (eoy) x16.028.6 55.8%  
Price / Book Value ratio x2.34.7 49.4%  
Dividend payout %25.130.8 81.4%   
Avg Mkt Cap Rs m24,57899,163 24.8%   
No. of employees `0005.22.9 179.6%   
Total wages/salary Rs m2,4872,758 90.2%   
Avg. sales/employee Rs Th2,928.36,981.7 41.9%   
Avg. wages/employee Rs Th479.4954.5 50.2%   
Avg. net profit/employee Rs Th209.4771.1 27.2%   
INCOME DATA
Net Sales Rs m15,19520,170 75.3%  
Other income Rs m110857 12.9%   
Total revenues Rs m15,30521,028 72.8%   
Gross profit Rs m1,7884,310 41.5%  
Depreciation Rs m4521,239 36.5%   
Interest Rs m345 648.1%   
Profit before tax Rs m1,4133,923 36.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m3261,794 18.2%   
Profit after tax Rs m1,0872,228 48.8%  
Gross profit margin %11.821.4 55.1%  
Effective tax rate %23.145.7 50.4%   
Net profit margin %7.211.0 64.8%  
BALANCE SHEET DATA
Current assets Rs m6,42616,299 39.4%   
Current liabilities Rs m3,9177,594 51.6%   
Net working cap to sales %16.543.2 38.3%  
Current ratio x1.62.1 76.4%  
Inventory Days Days6865 103.7%  
Debtors Days Days7726 299.0%  
Net fixed assets Rs m7,4108,622 85.9%   
Share capital Rs m182458 39.7%   
"Free" reserves Rs m10,45420,722 50.4%   
Net worth Rs m10,63621,180 50.2%   
Long term debt Rs m425 17.6%   
Total assets Rs m15,25829,137 52.4%  
Interest coverage x42.9755.5 5.7%   
Debt to equity ratio x00 35.0%  
Sales to assets ratio x1.00.7 143.9%   
Return on assets %7.37.7 95.8%  
Return on equity %10.210.5 97.1%  
Return on capital %13.619.0 71.6%  
Exports to sales %24.10.1 40,549.1%   
Imports to sales %4.917.5 28.3%   
Exports (fob) Rs m3,66612 30,547.5%   
Imports (cif) Rs m7523,526 21.3%   
Fx inflow Rs m5,29852 10,258.3%   
Fx outflow Rs m0140 0.0%   
Net fx Rs m5,298-88 -5,998.4%   
CASH FLOW
From Operations Rs m6833,436 19.9%  
From Investments Rs m-1,316-6,991 18.8%  
From Financial Activity Rs m592-619 -95.7%  
Net Cashflow Rs m-40-4,174 1.0%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 15.1 7.5 201.3%  
FIIs % 3.0 4.9 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.7 133.8%  
Shareholders   20,176 85,207 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 25, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS